Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 7
Diplomsko delo
Oznake: nujna bolezenska stanja;epileptični napad;astmatični napad;vročinski krč;alergijska reakcija;
Leto: 2021 Vir: Pedagoška fakulteta (UP PEF)
Diplomsko delo
Oznake: diplomska dela;zdravstvena nega;luskavica;nosečnost;zdravljenje;načrtovanje;
Uvod: Luskavica je avtoimuna bolezen, ki najpogosteje prizadene ženske v reproduktivni dobi. Zaradi pomanjkanja informacij o tem, kaj se dogaja z žensko, obolelo za luskavico in plodom oziroma otrokom pred in med nosečnostjo ter po porodu samem, je lahko za žensko nosečnost zelo stresna, predvsem če ...
Leto: 2021 Vir: Zdravstvena fakulteta (UL ZF)
Izvirni znanstveni članek
Oznake: protein 90 (Hsp90);inhibition of protein–protein interaction;virtual screening;ligand-based pharmacophore models;
The interaction between heat shock protein 90 (Hsp90) and Hsp90 co-chaperone cell-division cycle 37 (Cdc37) is crucial for the folding and maturation of several oncogenic proteins, particularly protein kinases. This makes the inhibition of this protein–protein interaction (PPI) an interesting target ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: analize;zaviralci;fenili;rak dojk;
Triple-negative breast cancer (TNBC) remains a treatment challenge and requires innovative therapies. Hsp90, crucial for the stability of numerous oncogenic proteins, has emerged as a promising therapeutic target. In this study, we present the optimization of the Hsp90 C-terminal domain (CTD) inhibi ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: cancer;Ewing sarcoma;Hsp90;inhibitor;topoisomerase IIα;zebrafish;
Heat shock protein 90 (Hsp90) and topoisomerase IIα (TopoIIα) are members of the GHKL protein superfamily, both with clinically validated roles as anticancer drug targets. We report the discovery of the first class of dual inhibitors targeting the ATP-binding site of TopoIIα and the C-terminal domai ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: cancer;Hsp90;isoform selectivity;topoisomerase II;
Due to their impact on several oncogenic client proteins, the Hsp90 family of chaperones has been widely studied for the development of potential anticancer agents. Although several Hsp90 inhibitors have entered clinical trials, most were unsuccessful because they induced a heat shock response (HSR) ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: cancer;Hsp90;inhibitor;Ewing sarcoma;zebrafish;
The development of new anticancer agents is one of the most urgent topics in drug discovery. Inhibition of molecular chaperone Hsp90 stands out as an approach that affects various oncogenic proteins in different types of cancer. These proteins rely on Hsp90 to obtain their functional structure, and ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Št. zadetkov: 7
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: